Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

IND filed for rhFXIII in patients with congenital FXIII deficiency

Sep. 20, 2002

CRL-42796 prevents experimental carotid and coronary artery thrombosis

Sep. 19, 2002

Coagulation factor inhibitors covered by Merck patent

Sep. 18, 2002

Merck & Co. presents new thrombin inhibitors

Sep. 17, 2002

New trypsin-like protease inhibitors and their use in thrombosis, cancer, etc.

Sep. 16, 2002

NO donor inhibits platelet deposition on damaged coronary vessels in pig model

Sep. 16, 2002

Sarpogrelate for muscle cramps in hemodialysis patients

Sep. 16, 2002

First filing made for new anticoagulant Exanta

Sep. 10, 2002

Data presented at ESC 2002 support further clinical evaluation of AR-C69931MX in myocardial ischemia

Sep. 9, 2002

Selective thrombin inhibitors identified by LEK and University of Ljubljana researchers

Aug. 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...